Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$340,200
+$8,289 QoQ
Shares Held
1,215
-2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#672
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $23,549,600 across 15 Diagnostics & Research names. LH ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
14,215 | $7,126,832 | |
| 2 | ILMN |
Illumina, Inc.
|
20,062 | $3,527,501 | |
| 3 | DHR |
Danaher Corp /De/
|
12,785 | $2,435,286 | |
| 4 | A |
Agilent Technologies, Inc.
|
12,431 | $1,651,209 | |
| 5 | QGEN |
Qiagen N.V.
|
41,657 | $1,628,788 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
2,829 | $1,498,210 | |
| 7 | WAT |
Waters Corp /De/
|
3,076 | $1,153,623 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
2,014 | $1,060,250 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $340,200 | 1,215 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $331,911 | 1,244 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $307,328 | 1,225 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $353,370 | 1,231 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $319,212 | 1,216 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $294,416 | 1,265 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $106,633 | 465 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $99,672 | 446 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $94,021 | 462 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||